Kiniksa Pharmaceuticals L... (KNSA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
20.55
-0.21 (-1.01%)
At close: Jan 28, 2025, 2:01 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | 14.08M | 183.36M | -157.92M | -161.38M | -161.87M | -103.23M | -64.87M | -23.97M |
Depreciation & Amortization | 2.34M | 2.40M | 2.35M | 2.40M | 2.07M | 286.00K | 28.00K | 22.00K |
Stock-Based Compensation | 27.15M | 25.12M | 25.17M | 20.88M | 15.08M | 5.70M | 897.00K | 368.00K |
Other Working Capital | 11.48M | -2.01M | 6.91M | 654.00K | -12.32M | 9.51M | 12.92M | 1.64M |
Other Non-Cash Items | 2.17M | 2.99M | 3.40M | 1.52M | 6.53M | -1.12M | -53.00K | 293.00K |
Deferred Income Tax | -33.79M | -185.50M | 11.00K | 4.36M | -3.16M | -978.00K | -197.00K | -46.00K |
Change in Working Capital | 1.35M | -22.57M | 689.00K | -4.32M | -17.02M | 18.33M | 13.93M | 1.76M |
Operating Cash Flow | 13.30M | 5.81M | -126.30M | -136.53M | -158.37M | -81.01M | -50.22M | -21.87M |
Capital Expenditures | -130.00K | -105.00K | -20.41M | -283.00K | -3.20M | -5.29M | -69.00K | -3.00K |
Acquisitions | n/a | 91.00K | 20.00M | 23.16M | -52.42M | n/a | n/a | n/a |
Purchase of Investments | -204.93M | -135.86M | -157.25M | -430.21M | -488.77M | -402.01M | n/a | n/a |
Sales Maturities Of Investments | 175.51M | 127.80M | 306.30M | 407.05M | 541.19M | 168.10M | n/a | n/a |
Other Investing Acitivies | n/a | -7.97M | -20.00M | -23.16M | 52.42M | -233.91M | n/a | n/a |
Investing Cash Flow | -29.56M | -8.08M | 128.63M | -23.44M | 49.21M | -239.20M | -69.00K | -3.00K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -2.21M | -901.00K | 5.88M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.70M | 3.42M | 5.88M | -1.14M | 1.00M | 187.54M | 39.87M | 42.51M |
Financial Cash Flow | 1.50M | 2.52M | 5.88M | 227.09M | 84.11M | 346.74M | 39.87M | 42.51M |
Net Cash Flow | -14.76M | 245.00K | 8.22M | 67.11M | -25.05M | 26.53M | -10.41M | 20.64M |
Free Cash Flow | 13.17M | 5.70M | -146.71M | -136.81M | -161.57M | -86.30M | -50.29M | -21.87M |